Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
43,302
Value
$2.48M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202643,302$2.48M<0.1%−3,974−8.4%ReducedHolders
Q1 202647,276$2.67M<0.1%−756−1.6%ReducedHolders
Q4 202548,032$2.85M<0.1%+5,502+12.9%AddedHolders
Q3 202542,530$2.30M<0.1%+2,636+6.6%AddedHolders
Q2 202539,894$2.19M<0.1%−5,876−12.8%ReducedHolders
Q1 202545,770$3.24M<0.1%+4,302+10.4%AddedHolders
Q4 202441,468$2.73M<0.1%+10,930+35.8%AddedHolders
Q3 202430,538$2.15M<0.1%+27,843+1,033.1%AddedHolders
Q2 20242,695$219.0K<0.1%−4,454−62.3%ReducedHolders
Q1 20247,149$626.0K<0.1%−1,111−13.5%ReducedHolders
Q4 20238,260$801.0K<0.1%+563+7.3%AddedHolders
Q3 20237,697$681.0K<0.1%+2,776+56.4%AddedHolders
Q2 20234,921$429.0K<0.1%+25+0.5%AddedHolders
Q1 20234,896$478.0K<0.1%−217−4.2%ReducedHolders
Q4 20225,113$527.0K<0.1%+315+6.6%AddedHolders
Q3 20224,798$406.0K<0.1%−5,091−51.5%ReducedHolders
Q2 20229,889$817.0K<0.1%−576−5.5%ReducedHolders
Q1 202210,465$808.0K<0.1%−10,346−49.7%ReducedHolders
Q4 202120,811$1.84M<0.1%+6,361+44.0%AddedHolders
Q3 202114,450$1.11M<0.1%+9,939+220.3%AddedHolders
Q2 20214,511$378.0K<0.1%+319+7.6%AddedHolders
Q1 20214,192$319.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.